聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 31 分钟 10 秒 前

Bionor Pharma Appoints Anker Lundemose as President and Chief Executive Officer

周二, 01/29/2013 - 13:29
The Appointment Considerably Strengthens Bionor Pharma's Partnering Capabilities OSLO, NORWAY--(Healthcare Sales & Marketing Network) - Bionor Pharma ASA ( OSLO : BIONOR ) today announced that Anker Lundemose, MD, PhD, DMSc (Medical Microbiology), has b...
Biopharmaceuticals, HIV/AIDS, Personnel
Bionor Pharma, Vacc-4x, vaccine

Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures

周二, 01/29/2013 - 13:05
LeGoo® proprietary gel technology provides clear surgical field for cardiothoracic and vascular surgeons without trauma to blood vessels BRIDGEWATER, N.J., Jan. 29, 2013 -- (Healthcare Sales & Marketing Network) -- Sanofi US announced the commercia...
Devices, Surgery, Product Launch
Sanofi, LeGoo, biopolymer gel, atraumatic occlusion, occlusion gel

Colibri Heart Valve Announces Issuance of a Patent for a Pre-mounted, Pre-packaged, Sterilized Dry Heart Valve on a Delivery System

周二, 01/29/2013 - 13:00
BROOMFIELD, CO, Jan. 29, 2013 -- (Healthcare Sales & Marketing Network) -- Colibri Heart Valve, LLC, a privately held medical device company, has been granted yet another patent directed to prosthetic heart valves. More particularly, today the U.S. Patent ...
Devices, Interventional Cardiology
Colibri Heart Valve, TAVI system, transcatheter, heart valve, aortic valve

Spectranetics Announces Expansion Into Japan Peripheral Intervention Market

周二, 01/29/2013 - 12:56
Market-Leading Quick-Cross(R) Support Catheter Receives Regulatory and Reimbursement Approval COLORADO SPRINGS, Colo., Jan. 29, 2013 -- (Healthcare Sales & Marketing Network) -- The Spectranetics Corporation today announced regulatory and reimbursement ...
Devices, Interventional, Regulatory
Spectranetics, Quick-Cross, Support Catheter, peripheral artery disease

FDA Grants Soligenix Fast Track Designation for OrbeShield(TM) for the Reduction of Mortality Associated with Gastrointestinal Acute Radiation Syndrome (GI ARS)

周二, 01/29/2013 - 12:52
PRINCETON, N.J., Jan. 29, 2013 -- (Healthcare Sales & Marketing Network) -- Soligenix, Inc. (SNGX) (Soligenix or the Company), a development stage biopharmaceutical company, announced today that its OrbeShieldTM (oral beclomethasone 17,21-dipropionate or ...
Biopharmaceuticals, FDA
Soligenix, OrbeShield, oral BDP, fast track designation, GI ARS

JointMetrix Medical Presents Novel Joint Monitoring Technology

周一, 01/28/2013 - 20:20
Company is Pioneering use of Remote Monitoring in Orthopaedics SEATTLE, Jan. 28, 2013 -- (Healthcare Sales & Marketing Network) -- JointMetrix Medical has developed novel remote monitoring technology for use in conjunction with joint replacement surger...
Devices, Orthopaedic, Monitoring
JointMetrix Medical, remote monitoring, joint replacement

Ocular Therapeutix, Inc. Closes on $23.8 Million Series D Extension

周一, 01/28/2013 - 19:36
BEDFORD, Mass.--(Healthcare Sales & Marketing Network)--Ocular Therapeutix, Inc. announced today it recently closed a Series D extension round of financing totaling $23.8 million. After considering offers from several new investors, the decision was made t...
Devices, Drug Delivery, Ophthalmology, Venture Capital
Ocular Therapeutix, drug-eluting punctum plug, ReSure Sealant

New NCCN Guidelines for Patients(R) Available for Adolescents and Young Adults with Cancer

周一, 01/28/2013 - 18:51
NCCN announces the availability of NCCN Guidelines for Patients®: Caring for Adolescents and Young Adults, a patient-friendly translation of the NCCN Guidelines® focused on people diagnosed with cancer between the ages of 15 and 39. FORT WASHIN...
Biopharmaceuticals, Devices, Oncology
National Comprehensive Cancer Network, NCCN, young adults with cancer

BrainStorm Cell Therapeutics Appoints Alon Natanson as Chief Executive Officer

周一, 01/28/2013 - 18:47
NEW YORK & PETACH TIKVAH, Israel--(Healthcare Sales & Marketing Network)--BrainStorm Cell Therapeutics (BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that it has appointed Mr. Alon Natanson as it...
Regenerative Medicine, Neurology, Personnel
BrainStorm Cell Therapeutics, stem cell

Cook Medical Introduces Flexor(R) Parallel(TM)

周一, 01/28/2013 - 16:49
BLOOMINGTON, Ind.--(Healthcare Sales & Marketing Network)--The only Food and Drug Administration (FDA) approved ureteral access sheath that has two options for placement is now available in the United States. The Flexor® Parallel™ Rapid Release™ Ureter...
Devices, Urology, Product Launch
Cook Medical, Flexor Parallel, Ureteral Access Sheath

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong